Bionime Rightest GM110
The technology used in the Bionime Rightest GM110, to measure blood glucose, has passed in a clinical validation study, in a general population, according to a recognised standard protocol, as published in a peer-reviewed publication.
|Medaval||Legacy approval||Older clinical validation; older protocol|
Hsu CT, Hsiao HC, Lee MS, Chang SF, Lee TC, Tsai YS, Zen JM. Assessing the quality of Bionime self-monitoring blood glucose system Rightest GM110: a critical evaluation of interference and ambient circumstances. Clin Chim Acta. 2009 Apr;402(1-2):119-23. Epub: 2009 Jan 5. doi: 10.1016/j.cca.2008.12.029. PMID: 19166825.
CLSI: 2002 - Pass General population